Linked Data API

Show Search Form

Search Results

1585235
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Strokes more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether he plans to incorporate the (a) national stroke service model and (b) integrated community stroke service model within the integrated urgent and emergency care workforce plans. more like this
tabling member constituency York Central more like this
tabling member printed
Rachael Maskell more like this
uin 142757 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>Workforce planning to meet appropriate care quality standards is a matter for the National Health Service.</p><p>We have commissioned NHS England to develop a long-term plan for the NHS workforce for the next 15 years. The NHS Long Term Workforce Plan will look at the mix and number of staff across all parts of the country and will set out the actions and reforms that will be needed to reduce supply gaps and improve retention.</p> more like this
answering member constituency Faversham and Mid Kent more like this
answering member printed Helen Whately more like this
question first answered
less than 2023-02-20T10:19:31.963Zmore like thismore than 2023-02-20T10:19:31.963Z
answering member
4527
label Biography information for Helen Whately more like this
tabling member
4471
label Biography information for Rachael Maskell more like this
1585237
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Prescription Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the Answer of 2 August 2022 to Question 39893 on Prescription Drugs: Addictions, if his Department will issue guidance for patients on tapering the dosage of prescription medicines to reduce the likelihood of an adverse event or withdrawal symptoms. more like this
tabling member constituency Lancaster and Fleetwood more like this
tabling member printed
Cat Smith more like this
uin 142742 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>The National Institute for Health and Care Excellence guidelines Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults includes information for both health professionals and patients on the safe withdrawal from medicines. The Department has no plans to issue separate guidance for patients.</p> more like this
answering member constituency Harborough more like this
answering member printed Neil O'Brien more like this
question first answered
less than 2023-02-20T10:24:04.597Zmore like thismore than 2023-02-20T10:24:04.597Z
answering member
4679
label Biography information for Neil O'Brien more like this
tabling member
4436
label Biography information for Cat Smith more like this
1585238
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Prescription Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether consideration was given to including guidance on (a) withdrawal from prescription drugs and (b) support for those withdrawing from prescription drugs in the (i) Structured medication reviews and medicines optimisation: guidance, published on 17 September 2020 and (ii) Good for you, good for us, good for everybody - A plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions, published on 22 September 2021. more like this
tabling member constituency Lancaster and Fleetwood more like this
tabling member printed
Cat Smith more like this
uin 142743 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>The Structured medication reviews and medicines optimisation guidance sets out implementation guidance for primary care networks (PCNs), including the principles of undertaking a structured medication review (SMR). The guidance provides approaches for health professionals to take when reviewing patients with complex and problematic polypharmacy, specifically those on 10 or more medications. This is not clinical guidance so does not provide detailed information about how medicines are to be withdrawn or stopped.</p><p>Any decision to withdraw a medicine would be carried out on an individual basis based on the patient’s individual clinical conditions, the medicines they are taking and their own values and preferences following a shared conversation between the patient and the prescriber.</p><p>In December 2018 the Government commissioned Dr Keith Ridge, the then Chief Pharmaceutical Officer for England, to lead a review into the use of medication and overprescribing, the outcome of this was published as ‘Good for you, good for us, good for everybody’. Some of the recommendations in the report are relevant to withdrawal from prescription drugs, including the expansion of Structured Medication Reviews across the National Health Service but do not specifically outline a recommendation to provide guidance on withdrawing prescription medicines.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-02-20T10:20:26.397Zmore like thismore than 2023-02-20T10:20:26.397Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4436
label Biography information for Cat Smith more like this
1585240
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Plastics: Health Hazards more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of establishing a fund for research into the potential impact of plastic on human health. more like this
tabling member constituency Ceredigion more like this
tabling member printed
Ben Lake more like this
uin 142898 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>No further assessment has been made. The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR funds research for the protection of public health from environmental hazards and to understand the complex role of the environment on disease development.</p><p>The NIHR is funding research on microplastic toxicity in humans through the NIHR Health Protection Research Unit in Environmental Exposures and Health, which is a partnership between Imperial College London and the UK Health Security Agency. This work will be reported in peer reviewed academic journals in due course.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-02-20T10:33:55.72Zmore like thismore than 2023-02-20T10:33:55.72Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4630
label Biography information for Ben Lake more like this
1585242
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Mental Health Services: Children and Young People more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 December 2022 to Question 99933 on Mental Health Services: Children and Young People, when he plans to take a decision on the potential introduction of a new waiting time standard that children, young people and their families and carers presenting to community-based mental health services should start to receive care within four weeks of referral; what estimate he has made of the level of any additional children and adolescent mental health service workforce that would be required to meet that new waiting time standard; and if he will make a statement. more like this
tabling member constituency Brighton, Pavilion more like this
tabling member printed
Caroline Lucas more like this
uin 142657 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>The Department and NHS England are working to establish the feasibility and associated risks of introducing new mental health waiting time standards, including one for children and young people’s community-based mental health services. As a first step, NHS England has shared and promoted guidance with its local system partners to consistently report waiting times to support the development of a baseline position.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2023-02-20T10:15:37.517Zmore like thismore than 2023-02-20T10:15:37.517Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
3930
label Biography information for Caroline Lucas more like this
1585243
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Mental Health Services: Children and Young People more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 December 2022 to Question 99933 on Mental Health Services: Children and Young People, whether he plans to introduce waiting time standards for children and young people's mental health services for (a) attention deficit hyperactivity disorder assessments, (b) autism assessments and (c) other assessments carried out by those services; what estimate he has made of the level of workforce required to meet (i) current and (ii) future demand for assessments carried out by those services; and if he will make a statement. more like this
tabling member constituency Brighton, Pavilion more like this
tabling member printed
Caroline Lucas more like this
uin 142658 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-22more like thismore than 2023-02-22
answer text <p>We have no plans to do so. We have also made no such estimates as this would be a matter for local commissioners and service providers.</p><p> </p><p>We are committed to ensuring people, including children and young people, can access attention deficit hyperactivity disorder assessments in a timely way and in line with the National Institute for Health and Care Excellence (NICE) guideline NG87: Attention deficit hyperactivity disorder: diagnosis and management. We are looking at how we can best achieve this.</p><p> </p><p>The waiting time standard for an autism assessment recommended by NICE is for a maximum waiting time of 13 weeks between a referral for assessment and a first appointment. We expect integrated care boards and providers to have due regard to NICE’s guidelines.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2023-02-22T10:10:02.157Zmore like thismore than 2023-02-22T10:10:02.157Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
3930
label Biography information for Caroline Lucas more like this
1585246
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Pethidine more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, for what reasons UK-manufactured pethidine supplies are not available as of 7 February 2023. more like this
tabling member constituency Battersea more like this
tabling member printed
Marsha De Cordova more like this
uin 142826 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>We are aware of supply issues with pethidine 50mg tablets until July 2023. However, alternative oral opioid analgesics remain available and clinicians who wish to continue to prescribe pethidine 50mg tablets can access these from specialist importers. Advice has been communicated to the National Health Service.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
grouped question UIN 141656 more like this
question first answered
less than 2023-02-20T09:20:12.57Zmore like thismore than 2023-02-20T09:20:12.57Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4676
label Biography information for Marsha De Cordova more like this
1585251
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the UK's share of the global pharmaceutical research and development market. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 142722 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-24more like thismore than 2023-02-24
answer text <p>The Department, alongside the former Department of Business, Energy and Industrial Strategy, have jointly commissioned an independent review of clinical trials. The review, currently underway, will offer recommendations on how commercial clinical trials can help the life sciences sector unlock United Kingdom growth and investment opportunities. It will also advise on how to resolve key challenges in conducting commercial clinical trials in the UK and will build on the 2021 publication of ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’. This vision sets out plans restructuring the UK’s research delivery to enable increased recruitment and market share of global trial numbers and aims to make study set-up and delivery faster, more efficient and more innovative. All of these measures will offer the assurance to global pharmaceutical companies that the UK remains one of the best places in the world to deliver cutting-edge research and increase the share of the global pharmaceutical research and development market.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-02-24T12:03:48.007Zmore like thismore than 2023-02-24T12:03:48.007Z
answering member
4423
label Biography information for Will Quince more like this
previous answer version
56368
answering member constituency Colchester more like this
answering member printed Will Quince more like this
answering member
4423
label Biography information for Will Quince more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this
1585252
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments: Innovation more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to help streamline processes for future medical innovations so they are available in similar timeframes to covid-19 treatments. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 142723 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>The Government is committed to supporting timely patient access to promising and innovative new treatments. Our Life Science Vision published in 2021 set out our ambition to build on the scientific successes and ways of working from COVID-19 to tackle the biggest disease challenges.</p><p>The United Kingdom’s participation in Project Orbis and the creation of the Innovative Licensing and Access Pathway (ILAP) are already enabling the more rapid review and approval of promising new medicines. In addition, the National Institute for Health and Care Excellence is introducing a more proportionate approach to appraisals that will create more flexibility in its medicine evaluation processes and speed up access for patients.</p> more like this
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-02-20T10:20:37.233Zmore like thismore than 2023-02-20T10:20:37.233Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this
1585253
registered interest false more like this
date remove filter
answering body
Department of Health and Social Care remove filter
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Disease Control more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department are taking to learn from best practice used during (a) the Covid-19 vaccination programme and (b) the response to the Covid-19 pandemic. more like this
tabling member constituency Cambridge more like this
tabling member printed
Daniel Zeichner more like this
uin 142724 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-02-20more like thismore than 2023-02-20
answer text <p>The United Kingdom’s vaccination programme, from research and development of vaccines against COVID-19 to the deployment to over 93% of the adult population aged 12 years old and over (as of 7 June 2022), has been one of the most successful and effective initiatives in the history of UK science and public administration. The Government is taking steps to learn from the best practice used during this programme.</p><p> </p><p>The Centre for Pandemic Preparedness within the UK Health Security Agency is working with partners in Government, academia and industry to understand the findings from evaluation of COVID-19 policies and exercises to identify lessons we can learn from for future incidents. We will also review the evidence base underpinning different policies and identify gaps.</p> more like this
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2023-02-20T10:40:11.577Zmore like thismore than 2023-02-20T10:40:11.577Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4382
label Biography information for Daniel Zeichner more like this